The effects of the stable expression of E1A and/or middle T oncogenes on the proliferative activity of PC Cl3 normal thyroid cells are reported. The proliferation of PC Cl3 cells is mainly regulated by insulin and TSH in a stimulatory way and by somatostatin in an inhibitory fashion. The transformed cell lines, named PC Py and PC E1A Py, show an autonomous pattern of proliferation. The blockade of phosphotyrosine phosphatase activity with vanadate increased the proliferation rate of PC Cl3 under basal and stimulated conditions and completely prevented the inhibitory activity of somatostatin, suggesting that in PC Cl3 cells, a tonic tyrosine phosphatase activity regulates basal and stimulated proliferation, and that a somatostatindependent increase in this activity may represent a cytostatic signal. Conversely, in both PC Py and PC E1A Py, vanadate did not modify basal and stimulated proliferation. We analyzed tyrosine phosphatase activity in the different cell lines basally and under conditions leading to the arrest of cell proliferation: confluence (contact inhibition), growth factor deprivation (starvation), and somatostatin treatment. Under basal conditions, tyrosine phosphatase activity was significantly lower in PC Py and PC E1APy cell lines than that in the normal cells. The inhibition of the proliferation induced by contact inhibition or somatostatin treatment was accompanied by an increase in tyrosine phosphatase activity only in PC Cl3 cells. The reduction in tyrosine phosphatase activity in PC E1APy cells correlated with a significant reduction in the expression of R-PTP, a tyrosine phosphatase cloned from PC Cl3 cells. Conversely, the expression of another receptor-like PTP, PTP, was unchanged. Thus, PTP may be a candidate to mediate inhibitory signals (i.e. activation of somatostatin receptors or cell to cell contact) on the proliferative activity of PC Cl3 cells, and the reduction of its expression in the transformed cell lines may lead to an alteration in the control of cell proliferation.
leading to the arrest of cell proliferation: confluence (contact inhibition), growth factor deprivation (starvation), and somatostatin treatment. Under basal conditions, tyrosine phosphatase activity was significantly lower in PC Py and PC E1APy cell lines than that in the normal cells. The inhibition of the proliferation induced by contact inhibition or somatostatin treatment was accompanied by an increase in tyrosine phosphatase activity only in PC Cl3 cells. The reduction in tyrosine phosphatase activity in PC E1APy cells correlated with a significant reduction in the expression of R-PTP, a tyrosine phosphatase cloned from PC Cl3 cells. Conversely, the expression of another receptor-like PTP, PTP, was unchanged. Thus, PTP may be a candidate to mediate inhibitory signals (i.e. activation of somatostatin receptors or cell to cell contact) on the proliferative activity of PC Cl3 cells, and the reduction of its expression in the transformed cell lines may lead to an alteration in the control of cell proliferation. (Endocrinology 138: 3756 -3763, 1997) N UMEROUS experimental and clinical evidence support the hypothesis that carcinogenesis in vivo is a complex multistep process (1) . The study of the age-dependent tumor incidence, allowed the development of mathematical models of carcinogenesis that involve as many as five or six independent steps, each of which is rate limiting (2, 3) . In the intact host, each step would represent a physiological barrier to be overcome by a cell to progress toward malignant transformation. The existence of multiple barriers ensures that the insurgence of tumors is a relatively rare event.
Thyroid tumors represent a powerful model to evaluate the roles of many different genetic and/or environmental factors in predisposing the formation of benign nodule formation, differentiated malignant tumors, and anaplastic cancer. Although these histological changes are not necessarily sequential, a gradation of the proliferative and differentiative potential among the cells of each thyroid follicle exists (3) . For example, although the transition from benign nodule into well differentiated carcinoma is only speculative to date, there is evidence showing that well differentiated carcinomas may evolve into anaplastic tumors (3) .
In the past years we developed a suitable in vitro model in which the number and the nature of the genes involved in epithelial malignant transformation could be assayed to study the relationship between oncogene products and specific growth regulatory pathways (4) . In particular, we used PC Cl3 cells, an established thyroid epithelial cell line derived from adult Fisher rats, that retain in vitro most of the features of the differentiated thyroid cells and subclones of these cells in which are expressed the viral oncogenes E1A and/or middle T. Thus, we obtained four different cell lines representing a gradient of malignant transformation. In particular, the wild-type PC Cl3 retain in vitro most of the typical markers of thyroid differentiation, such as dependence on TSH for proliferation and functioning, thyroglobulin synthesis and secretion, and the ability to trap iodide from the medium (4) . PC E1A cells originate by stable transfection of PC Cl3 cells with the E1A oncogene, do not synthesize thyroglobulin, and are partially independent of TSH for their growth, but are not tumorigenic when injected into nude mice. PC Py cells are generated by the infection of PC Cl3 cells with the murine leukemia virus (PyMLV) carrying the middle T oncogene; these cells, while maintaining some differentiative markers of thyroid cells (i.e. thyroglobulin synthesis), are partially independent from TSH and are tumorigenic in nude mice with a latency of 3-4 weeks. PC E1APy cells represent PC Cl3 cells receiving both E1A transfection and infection with PyMLV carrying the middle T oncogene; these cells display the most malignant phenotype, having lost all of the differentiative features of the thyroid cells, are completely independent from TSH for their proliferation, and are tumorigenic in nude mice with a very short latency (Ͻ10 days) (4 -7) .
Somatostatin is one of the main endogenous inhibitors of cell proliferation (8 -10) . It has been recently emphasized that the modulation of phosphotyrosine phosphatase (PTP) activity is an important intracellular pathway responsible for somatostatinergic inhibition of cell growth (11) (12) (13) (14) . It was reported that the somatostatin-dependent increase in PTP activity induces the dephosphorylation of the epidermal growth factor receptor, a tyrosine kinase activated by tyrosyl phosphorylation, and that this effect results in the inhibition of the proliferative activity of epidermal growth factor (12, 15) . Moreover, the effect of somatostatin involved a single subset of PTPs rather than a nonspecific activation of all of the components of this class of enzymes (16, 17) . Other neurohormones, such as dopamine (18) and LHRH (19, 20) , have also been reported to induce growth arrest through the induction of PTP activity, and in human breast cancer cells, treatment with antiestrogens increases a membrane PTP activity that is strictly correlated with their antiproliferative effects (21) . Thus, hormonally regulated PTPs seem to play a key role in the control of cell proliferation, and somatostatin is suggested to be an important endogenous modulator of the activity of this class of enzymes.
We previously used the PC Cl3 cell line to evaluate the role of somatostatin in the regulation of thyroid cell proliferation, the intracellular mechanisms involved, and the effect of E1A stable expression in these cells (PC E1A). We showed that somatostatin was able to powerfully inhibit insulin-and insulin-plus TSH-dependent cell proliferation by inducing a block of the G1 to S progression in the cell cycle (22) . These cytostatic effects were completely reverted by vanadate, suggesting that somatostatin may induce antiproliferative effects through the modulation of phosphotyrosine phosphatases (22) . In the E1A-transformed cell line, somatostatin was completely ineffective (22) . The lack of somatostatin inhibitory effects on cell proliferation were not due to alterations in the expression of somatostatin receptors that were regularly expressed and coupled to adenylyl cyclase activity, but was dependent on an alteration in their coupling with the phosphotyrosine phosphatase. In fact, although in PC Cl3 cells somatostatin increased phosphotyrosine phosphatase activity by 100%, it was completely ineffective in E1A-expressing cells (22) .
In the present study we report characterization of the proliferative features of the PC Py and PC E1APy cell lines compared with those of the wild-type PC Cl3 cells. We demonstrated that the middle T and E1A oncogene transformation induces an autonomous pattern of proliferation in these thyroid cells, which become insensitive to either stimulatory (insulin and TSH) or inhibitory (somatostatin) hormones. Moreover, the lack of the inhibitory proliferative response to both somatostatin and cell contact correlates with the alteration in PTP activity.
Materials and Methods Materials
Somatostatin-14 was purchased from American Peptides (Sunnyvale, CA), vanadate was obtained from Alomone Laboratories (Jerusalem, Israel), and all other reagents were obtained from Sigma Chemical Co. (St. Louis, MO) unless otherwise specified.
Cell culture
PC Cl3 and PC Py cell lines were grown in Ham's F-12 medium, Coon's modification (Sigma), supplemented with 5% FCS (ICN-Flow, Irvine, CA) and six growth factors [10 nm TSH, 10 nm hydrocortisone, 100 nm insulin, 5 g/ml transferrin, 5 nm somatostatin, and 20 g/ml glycyl-histydyl-lysine (6H)], as previously reported (23) . As somatostatin reduced the proliferation rate of these cells, it was removed from the 6H mixture. PC E1APy were grown in the same medium without growth factor mixture.
[ 3 H]Thymidine incorporation assay
DNA synthesis activity was measured by means of the [ 3 H]thymidine uptake assay as previously reported (18) . Briefly, cells were plated at a density of 5 ϫ 10 5 in 24-well plates. After 24 h, cells were serum and growth factor starved for 48 h. Subsequently, cells were treated with the test substances for 16 h, and in the last 4 h, they were pulsed with 1 Ci/ml [ 3 H]thymidine (Amersham, Arlington Heights, IL). At the end of the incubation, cells were trypsinized (15 min at 37 C), extracted in 10% trichloroacetic acid (TCA), and filtered under vacuum through fiber-glass filters (GF/A, Whatman, Clifton, NJ). The filters were then washed sequentially under vacuum with 10% and 5% TCA and 95% ethanol. The TCA-insoluble fraction was then counted in a scintillation counter.
Cell cycle analysis by propidium iodide staining
Cells treated at different times were harvested by trypsinization, pelleted, washed twice with calcium-and magnesium-free PBS, fixed, and permeabilized with cold 70% ethanol and then stored at 4 C. One milliliter of propidium iodide staining solution (50 g/ml in PBS, pH 7.4) containing 0.5 mg/ml deoxyribonuclease-free ribonuclease was added to 2 ϫ 10 6 cells (30 min at room temperature), and the DNA content of the cells was analyzed by a FACScan flow cytometer apparatus (Becton and Dickinson, Mountain View, CA). Cell cycle data analysis was performed on 20,000 events by Cell-Fit software (Becton and Dickinson), using the method of Dean (24) . Pulse area vs. pulse width gating was performed to exclude doublets from G2/M region.
PTP assay
Cells plated at 50% confluence in 10-cm petri dishes were preincubated with the test substances for 2 h in FCS-free medium at 37 C in a CO 2 incubator. Then, the cells were washed with PBS and mechanically scraped in a buffer containing 0.32 m sucrose, 10 mm Tris (pH 7.5), 5 mm EGTA, and 1 mm EDTA, and the membranes were isolated as previously reported (25) . Nuclei were removed by centrifugation at 2,000 ϫ g at 4 C for 10 min. The membrane fraction was sedimented by an additional centrifugation at 15,000 ϫ g at 4 C for 60 min; resuspended in a buffer containing 250 mm HEPES (pH 7.2), 140 mm NaCl, 1% Nonidet P-40, and phenylmethylsulfonylfluoride and leupeptin as protease inhibitors; and assayed for protein content using the method of Bradford (26) with BSA as standard and the Bio-Rad reagent (Bio-Rad, Richmond, CA). Twenty micrograms of control or treated membranes were used in the PTP assay. The PTP assay was performed using the synthetic substrate para-nitrophenylphosphate (p-Npp) in a spectrophotometric assay. p-Npp is a general phosphatase substrate that in the presence of inhibitors of Ser/ Thr phosphatases is specific for PTPs (8, 14) . Membranes were preincubated for 5 min at 30 C in an 80-l volume containing 20 l of a 5-fold concentrated reaction buffer [250 mm HEPES (pH 7.2), 50 mm dithiothreitol, 25 mm EDTA, 500 nm microcystin-leucine-arginine (Alomone Laboratories) as a Ser/Thr phosphatases inhibitor, and 50 m ZnCl 2 ]. The reaction was started by adding 20 l 50 mm p-Npp, was carried out for 30 min at 30 C, and was stopped by adding 900 l 0.2 n NaOH. The absorbance of the sample, directly proportional to the amount of dephosphorylated substrate, was measured at 410 nm (27) . The extinction coefficient for p-Npp at this wavelength is 1.78 ϫ 10 4 m Ϫ1 cm Ϫ1 (27) .
Messenger RNA (mRNA) analysis
The expression of specific mRNAs was evaluated by means of the reverse transcription-PCR (RT-PCR) technique for the somatostatin receptor subtypes and by means of the Northern blot technique for R-PTP and PTP, as described below.
RNA isolation and RT-PCR
Total RNA was isolated using the acidic phenol technique (28) . RT-PCR was performed using the RNA-PCR kit (Perkin-Elmer, Norwalk, CT) following the manufacturer's instructions. Briefly, the RT reaction was performed on 1 g total RNA, using the specific downstream primer. The samples, in a final volume of 50 l, were incubated for 1 h at 60 C. The PCR reaction was immediately performed in the same tube (40 cycles of 1 min at 94 C, 1 min at 60 C, and 1 min at 72 C, followed by 7 min at 72 C). Amplified DNA fragment was then visualized by agarose gel electrophoresis. The primers used were the following: SSTR1, 5Ј-sense primer corresponding to amino acids 86 -91 and 3Ј-antisense primer corresponding to amino acids 211-217 of the SSTR1 sequence; SSTR2, 5Ј-sense primer corresponding to amino acids 71-77 and 3Ј-antisense primer corresponding to amino acids 195-181 of the SSTR2 sequence; SSTR3, 5Ј-sense primer corresponding to amino acids 189 -196 and 3Ј-antisense primer corresponding to amino acids 304 -311 of the SSTR3 sequence; SSTR4, 5Ј-sense primer corresponding to amino acids 284 -291 and 3Ј-antisense primer corresponding to amino acids 367-374 of the SSTR4 sequence; SSTR5, 5Ј-sense primer corresponded to amino acids 270 -276 and 3Ј-antisense primer corresponded to amino acids 354-3621 of the SSTR5 sequence. The expected lengths for the amplified products were the following: SSTR1, 395 bp; SSTR2, 392 bp; SSTR3, 370 bp; SSTR4, 270 bp; and SSTR5, 275 bp.
Northern blot
Northern blot and hybridization procedures were performed according to standard procedures (29) . A mouse ␤-actin probe was used to ascertain equal RNA loading (30).
Statistical analysis
Experiments were performed in quadruplicate and repeated at least three times. Statistical analysis was performed by means of one-way ANOVA. P Ͻ 0.05 was considered statistically significant.
Results
The growth characteristics of PC Cl3, PC Py, and PC E1APy cell lines were studied by means of both flow cytometry and [
3 H]thymidine incorporation analysis. In Table  1 is presented the DNA synthesis activity, assayed by means of [ 3 H]thymidine incorporation, under serum-and growth factor-starved conditions (48 h) or after readministration of the growth factor mixture (see Materials and Methods).
The data obtained showed that removal of growth factors from the culture medium affected mainly the DNA synthesis activity of the PC Cl3 cells, which was brought to background levels and was restored only after readministration of the hormones, whereas the PC Py and PC E1APy cells showed a completely autonomous pattern of growth; DNA synthesis was only slightly reduced by starvation and, especially in the PC E1APy, was almost insensitive to readministration of the growth factor mixture. These observations were confirmed in flow cytometry experiments that showed that PC Cl3 cells were completely synchronized after 48 h of serum and growth factor removal (Ͼ95% of cells in G0/G1), whereas PC Py and PC E1APy in the same experimental conditions still showed a high percentage of cycling cells (30.5% and 43.2% in the S phase and 10% and 12% in G2/M phases, respectively). Analogous results were obtained by evaluating the inhibitory control of cell proliferation exerted by somatostatin under both insulin-and insulin-plus TSH-stimulated conditions.
In PC Cl3 cells, in agreement with our previous report (22) , somatostatin (1 m) powerfully inhibited insulin-and insulin-plus TSH-stimulated DNA synthesis (Ϫ40%), whereas no effect was observed in PC Py and PC E1APy cell lines (Fig.  1) . Similarly, flow cytometry studies demonstrated that somatostatin was able to prevent the G1/S progression in the cell cycle induced by both insulin and insulin and TSH, with a maximal effect after 16 h of treatment (Table 2) . Longer treatments were ineffective in this respect (Table 2) .
In neither of the transformed cell lines was a significant increase in cycling cell population observed after insulin-and insulin plus TSH treatments nor was any inhibitory effect induced by somatostatin treatment at times tested (up to 40 h; Tables 3 and 4) . A role for phosphotyrosine phosphatases in the hormonal control of cell proliferation was recently proposed (31, 32) . Thus, we evaluated the effect of the blockade of tyrosine phosphatases induced by pretreatment with vanadate (33) on both the stimulation of DNA synthesis induced by insulin or insulin plus TSH and the inhibition caused by somatostatin.
In PC Cl3 cells, vanadate increased basal and stimulated [ 3 H]thymidine uptake and completely prevented the inhibitory activity of somatostatin (Fig 2a) . Conversely, in the transformed cell lines, the blockade of PTPs had no effect on the proliferative rate of these cells under either basal or stimulated conditions (Fig. 2, b and c) .
The lack of inhibitory effects of somatostatin in PC Py and PCE1APy cells was not due to alterations in the pattern of SSTRs expression. Indeed, in all cell lines, the same pattern of SSTR mRNA expression was observed by means of RT-PCR, showing the presence of transcripts for SSTR2, SSTR4, and SSTR5 (data not shown).
Thus, we directly measured the PTP activity in membrane preparations from the different cell lines, evaluating the modulation of PTP activity by different treatments leading to growth arrest, namely serum and growth factor deprivation (starvation), confluence (contact inhibition), and somatostatin treatment.
In PC Cl3 cells, both contact inhibition and somatostatin treatment (1 m, 2 h) significantly increased PTP activity, whereas serum and growth factor deprivation slightly reduced it, although the latter effect was not statistically significant (Fig 3) .
In PC Py and PC E1APy cells, basal PTP activity was lower than that in the PC Cl3 cell line (Ϫ40% and Ϫ70%, respectively; Fig. 4 ) and was not induced by cell contact or somatostatin treatment. Serum deprivation also did not modify PTP activity (Fig. 3) .
Therefore, it seems likely that an alteration in basal PTP activity and its modulation by growth inhibitory treatments may be responsible for the alteration in the proliferative activity of the transformed cell lines. As the reduction in PTP activity was much more pronounced in PC E1APy membrane preparations than in total cell lysate (Ϫ70% vs. Ϫ35%, respectively), we tried to identify at the molecular level the alteration induced by oncogene expression in the PTP pathway, evaluating the expression of a receptor-like membraneassociated PTP recently cloned from a PC Cl3 library, R-PTP (34), representing the rat homolog of the human PTP (35, 
36). Using
Northern blot analysis, we demonstrated that R-PTP mRNA was expressed in PC Cl3 cells, but it was reduced in PC E1A and PC Py cells, and it was almost undetectable in PC E1APy cells (Fig. 4) . By means of evaluation of ␤-actin mRNA expression, it was demonstrated that equal amounts of RNA were loaded in all lanes (data not shown). Moreover, the expression of another receptor-like PTP, PTP, was not altered in the transformed cell lines (data not shown), thus suggesting that the oncogene expressiondependent reduction of PTP activity was probably mainly due to a decrease in PTP gene expression.
Discussion
In the present study we have characterized the role of PTPs in the control of cellular proliferation in PC Cl3 clonal thyroid cells and the alterations that occurred in the regulation of this enzymatic pathway after stable expression in these cells of the E1A and middle T oncogenes.
PC Cl3 cells are mainly dependent on insulin and TSH for proliferation (22) . In these cells, the expression of the middle T oncogene (PC Py cells) or the E1A and middle T (PC E1APy) oncogenes induced a relative independence from these factors, more marked in the PC E1APy cells, as shown by the high percentage of cells in the S phase of the cell cycle in cells grown in the absence of insulin and TSH. This effect seems to be dependent mainly on the middle T oncogene expression, as we previously reported that in another cell line derived from PC Cl3 cells expressing only the E1A oncogene, although we observed a higher proliferation rate than that in normal cells, the responsivity to insulin and TSH in G0/G1 synchronized cells was not changed, showing that this cell line still needs external stimulatory signals to proliferate (22) . However, in the present study the two oncogenes cooperated, inducing a significantly higher degree of independence from the stimulatory signals. Middle T oncogene was reported to interfere with the activity of many different proteins, including protein phosphatase 2A, pp60 c-src, phosphatidylinositol 3-kinase, and Shc among them (37, 38) . To try to dissect the possible mechanisms by which middle T expression may affect PC Cl3 cell proliferation, we analyzed the proliferative responses to insulin and TSH of wild-type PC Cl3 cells in cells pretreated with okadaic acid to bock PP2A activity. Under these experimental conditions we did not find any significant alteration in the responses of the cells to both insulin and insulin plus TSH treatments (data not shown). This observation probably suggests that the middle T-dependent cell transformation requires the alteration of different intracellular pathways.
In PC Cl3 cells, somatostatin inhibited the induction of DNA synthesis stimulated by insulin and the synergic activation induced by insulin and TSH. FACS analysis demonstrated that somatostatin exerted its antiproliferative effects by slowing down the G1 to S progression, with a maximal efficacy after 16 h of treatment, in agreement with previous studies in this (22) and other (39) cell lines. Conversely, in the transformed cell lines, somatostatin was completely ineffective in reducing cell proliferation, although the same pattern of SSTR mRNA expression was observed in all cell lines. These data indicate that the expression of E1A and middle T oncogenes renders the cells completely independent of both stimulatory and inhibitory regulators of cell proliferation. Pretreatment of PC Cl3 cells with the competitive inhibitor of PTPs, vanadate (32) , almost doubled basal and stimulated (insulin and insulin plus TSH) DNA synthesis activity, indicating that the normal thyroid cell line is under the control of basal PTP activity tone, which regulates the proliferation rate of these cells. Moreover, vanadate pretreatment abolished the somatostatinergic inhibition of DNA synthesis, suggesting that somatostatin may exert direct antiproliferative effects through the activation of PTPs.
Vanadate pretreatment did not modify the proliferative activity of PC Py and PC E1APy cells under either basal or insulin-or insulin-plus TSH-stimulated conditions. This observation strongly suggests that an alteration in the activity of some member of the PTP family may be induced by the oncogenic transformation. The direct analysis of the total membrane PTP activity seems to support this hypothesis. In fact, in the PC Py and PC E1APy cell lines, basal PTP activity measured as hydrolysis of the synthetic substrate pNPP, was less than one third the activity in PC Cl3 cells.
PTPs have been proposed to act as antioncogene molecules to counteract the tyrosine kinase activity of many oncogenes and growth factors (31) , thus the great reduction in the activity of these enzymes that we observed in the transformed cell lines may contribute to the abnormal proliferative features of these cells. The disruption of this regulatory pathway seems again to be ascribed mainly to the middle T oncogene expression, as in another PC Cl3-derived cell line expressing only the oncogene E1A (PC E1A), basal PTP activity was unaltered (22) .
To better evaluate the role of PTP in the growth arrest process in the PC Cl3 cells, we measured PTP activity under different conditions that caused the cells to stop proliferating. In particular, we analyzed PTP activity after serum and growth factor deprivation and somatostatin receptor stimulation, which was reported, in this and previous studies (22, 39) , to induce an arrest in the G0/G1 phases of the cell cycle, and after the cells had been grown to confluence. Under these conditions, normal cells stop dividing due to contact inhibition mediated by the neighbor cells through an as yet unidentified mechanism. Conversely, transformed cells no longer respond to the constraints of their neighbors and divide uncontrollably (40) .
In the normal cell line (PC Cl3), the simple removal of growth factors, although leading to G0/G1 arrest, did not modify PTP activity, but probably acted through suppression of phosphorylative stimuli. On the other hand, both somatostatin treatment and contact inhibition induced a significant increase in PTP activity, clearly indicating that membrane-associated PTPs are important mediators of both hormonal and physical regulation of cell proliferation. In PC Py and PC E1APy cells, none of these treatments was able to modify PTP activity, which remained much lower than the basal PTP activity of PC Cl3 cells.
As a possible molecular correlate for the impairment of PTP activity responsible for the alterations in cell growth regulation, after E1A and/or middle T oncogene expression we analyzed the levels of mRNA expression of a receptor-like PTP, named R-PTP, cloned from PC Cl3 cells (34) . R-PTP was expressed in the normal cells, but the levels of the transcript were dramatically reduced in the transformed cell lines. The level of expression of R-PTP mRNA was positively correlated with the degree of loss of differentiative markers in the different cell lines, being almost undetectable in the PC E1A PY cells. Conversely, the expression of PTP mRNA, another receptor-like PTP, was unchanged, suggesting that the alteration observed was rather specific.
Thus, a reduction of the expression of PTP may account for the loss of responsivity to somatostatin in the transformed cell lines. Interestingly, the transfection of an R-PTP complementary DNA in the PC E1APy cells markedly reduced the tumoricigenicity of these cells implanted in nude mice (Fusco, A., and M. T. Berlingieri, unpublished results), thus supporting the hypothesis that the inhibition of expression represents one of the major molecular correlates of the transformed phenotype observed in PC E1APy cells. However, as it was recently reported that somatostatin receptors are coupled to other PTPs (SH-PTP1 and SH-PTP2) (41, 42) in different cell systems, the involvement of alteration of this phosphatase activity during middle T-dependent cell transformation cannot be ruled out.
In conclusion, our data demonstrated that the expression of middle T and E1A plus middle T oncogenes in the PC Cl3 thyroid cell line induced a transformed phenotype, resulting in a completely autonomous pattern of proliferation. Moreover, loss of the regulation of the proliferative pathway correlated with a reduction in the expression of R-PTP and a severe impairment of basal and stimulated PTP activity, thus suggesting a pivotal role for these enzymes in the normal control of thyroid cell proliferation. 
